Background and purpose: To determine the rate of peri-interventional silent brain infarcts after left atrial appendage occlusion (LAAO). Methods: In this prospective, uncontrolled single-center pilot study, consecutive patients with atrial fibrillation undergoing LAAO between July 2013 and January 2016 were included. The Amplatzer Cardiac Plug, WATCHMAN or Amulet device was used. A neurological examination and cranial magnetic resonance imaging (MRI) were performed within 48 h before and after the procedure. MRI was evaluated for new diffusion-weighted imaging (DWI) hyperintensities, cerebral microbleeds (CMBs) and white-matter lesions (WMLs). Results: Left atrial appendage occlusion was performed in 21 patients (mean age, 73.2 AE 9.5 years). Main reasons for LAAO were previous intracerebral hemorrhage (n = 11) and major systemic bleeding (n = 6). No clinically overt stroke occurred peri-interventionally. After the intervention, one patient had a small cerebellar hyperintensity on DWI (4.8%; 95% confidence interval, 0.0-14.3) that was not present on the MRI 1 day before the procedure. Among 11 patients with available MRI just before LAAO, there were no significant changes in the number of CMBs and the severity of WMLs after LAAO. Conclusions: This study of peri-interventional MRI in LAAO suggests a low rate of silent peri-procedural infarcts in this elderly population. Confirmation in larger studies is needed.
Introduction
Oral anticoagulation is the standard therapy for patients with atrial fibrillation (AF) and an increased thromboembolic risk. In patients with AF in whom long-term anticoagulation is contraindicated, American and European management guidelines consider left atrial appendage occlusion (LAAO) an alternative [1] .
In randomized clinical trials, registries and observational studies of LAAO, overt peri-procedural ischaemic strokes occurred in 0.0-6.7% of patients [2, 3] . In addition to overt strokes, cardiovascular procedures can lead to clinically silent cerebral embolic infarcts [4, 5] that can be uncovered by magnetic resonance imaging (MRI). Peri-procedural silent infarcts on MRI have been investigated in persistent foramen ovale (PFO) closure [6, 7] , pulmonary vein ablation [5, 8] , transfemoral aortic valve implantation [4] , carotid artery stenting [9] and carotid endarterectomy [9] . Periprocedural overt strokes were reported in 0.38-5.6% of these procedures [4] [5] [6] [7] [8] [9] . The frequency of silent infarcts varied between 4% and 90% [4, [7] [8] [9] . We performed a prospective pilot study using MRI to describe the frequency of silent cerebral infarcts after LAAO. approval by the local institutional review board. All participants provided informed consent. Between July 2013 and January 2016, we screened consecutive patients aged ≥18 years with documented non-valvular AF who were scheduled to undergo LAAO. Exclusion criteria were another indication for oral anticoagulation and contraindications for MRI. The medical history, basic demographic variables, National Institutes of Health Stroke Scale, modified Rankin Scale, a clinical prediction rule for estimating the risk of stroke in patients with non-rheumatic atrial fibrillation (CHA 2 DS 2 Vasc score), a score to assess the 1-year risk of major bleeding in patients with atrial fibrillation (HAS-BLED score) and the reasons leading to LAAO were recorded. Study endpoints were acute ischaemic or hemorrhagic lesions on MRI and any changes on neurological examination within 48 h after the procedure.
Materials and methods

Left atrial appendage occlusion
Left atrial appendage occlusion was performed by two interventional cardiologists. Transesophageal echocardiography combined with fluoroscopy was used for guidance. The left atrium was accessed after right femoral vein puncture and septal penetration. The occluder (Amplatzer Cardiac Plug or Amulet device, both St Jude Medical, Saint Paul, MN, USA or WATCHMAN TM device, Boston Scientific, Marlborough, MA, USA) was advanced into the left atrial appendage. For peri-procedural anticoagulation, unfractioned heparin was used and administered intravenously, monitored by the activated clotting time (goal, 250-300 s). After LAAO, all patients received aspirin (100 mg) and clopidogrel (75 mg) daily for 3 months followed by aspirin monotherapy.
Imaging protocol
Magnetic resonance (MR) images were acquired using a 3 Tesla MR system (Magnetom Tim Trio or Verio, Siemens Healthcare, Germany; identical parameters) with a 12-channel head-matrix coil. Diffusionweighted imaging (DWI), including apparent diffusion coefficient (ADC), was acquired using a single-shot spin-echo echo-planar sequence [repetition time, 3000 ms; echo time, 86 ms; section thickness, 5 mm; field of view, 230 9 230 mm; b value, 0 and 1000 s/mm 2 (high b value in three orthogonal directions)]. Parameters of the fluid-attenuated inversion recovery (FLAIR) scans included: inversion time, 2400 ms; echo time, 135 ms; repetition time, 8500 ms; flip angle, 170°; bandwidth, 150 Hz/px; acquisition matrix, 256 9 192 9 26; voxel size, 0.9 9 0.9 9 5 mm; section thickness, 5 mm. Susceptibilityweighted imaging was performed with a three-dimensional, fully flow-compensated gradient-echo sequence (echo time, 19.7 ms; repetition time, 27 ms; flip angle, 15°; bandwidth, 140 Hz/px; acquisition matrix, 320 9 240 9 52; voxel size, 0.72 9 0.72 9 2.5 mm; section thickness, 2.5 mm).
Two neuroradiologists (M.M. and J.P.) independently assessed MRI blinded to the time of examination. DWI was reviewed for focal hyperintensities with corresponding hypointensities on ADC maps. To evaluate the extent of white-matter lesions (WMLs), FLAIR sequences were graded using the Scheltens score [5] . For patients who had undergone MRI ≤48 h before LAAO, pre-and post-interventional cerebral microbleeds (CMBs) and WMLs were compared. CMBs were rated as described previously [10] .
Statistical analysis
Categorical data were reported in absolute and relative frequencies. Continuous variables were presented as means and SD or medians and interquartile ranges (IQRs). Mean values of both raters' pre-and postinterventional CMBs and Scheltens scores [5, 10] were calculated. CMBs and WMLs were compared using Wilcoxon signed-rank test. P ≤ 0.05 was considered statistically significant. Inter-rater reliability was calculated using Cohen's kappa. Spearman correlation was used to compare Scheltens scores. Data were analyzed using SPSS (version 22.0; IBM, Armonk, NY, USA).
Results
Of 41 patients undergoing the LAAO procedure during the study period, 21 were included in the analysis (Fig. 1) . Baseline characteristics are displayed in Table 1 .
No patient had a clinically overt stroke upon postinterventional evaluation. One patient with a history of symptomatic epilepsy had a focal seizure.
Only one patient had a new focal DWI hyperintensity with a corresponding ADC hypointensity and a corresponding FLAIR hyperintensity in the left cerebellum compared with pre-procedural scans (Fig. 2) . Inter-rater reliability for DWI hyperintensities was 1.0.
Of 11 MR images available within 48 h before LAAO, nine patients (81.8%) had at least one CMB and all had at least one WML before the procedure. 
Discussion
This pilot study using peri-procedural MRI found a low rate (4.8%) of new silent infarcts after LAAO. Compared with other trans-septal procedures, the incidence of subclinical brain infarcts of 4.8% after LAAO in our study is within the rate reported for PFO (3.3-8.6%) [6, 7] but lower than that reported after pulmonary vein isolation (14.3-41%) [8] . Patients undergoing PFO closure in previous peri-interventional imaging trials were considerably younger (mean age, 42-45 years) [6, 7] than our patients with AF (mean age, 73.2 years) and would therefore be expected to have a lower risk of thromboembolic complications for cardiovascular interventions. In contrast, 75-90% of patients undergoing transfemoral aortic valve implantation, who are frequently octogenarians, had silent cerebral infarcts reflecting the procedural complexity and thrombogenicity of the underlying disorder [4] . Explanations for the lower rate of subclinical brain infarcts after LAAO compared with pulmonary vein isolation may be shorter procedure times, less mechanical manipulation in the left atrium and no ablation in LAAO. In carotid interventions, the average rate of new DWI lesions was 37% after stenting but only 10% after endarterectomy [9] .
New post-interventional DWI lesions are considered a surrogate marker for the procedural risk of embolism. Their impact on the patient's cognitive and motor function, however, remains controversial. In studies correlating DWI lesions and cognitive function in cardiovascular procedures, no relationship between peri-procedural cognitive dysfunction and silent DWI lesions could be established [8] . Further studies with combined MRI and longitudinal neuropsychological assessment might clarify the clinical significance of silent post-procedural DWI lesion. More than 75% of our patients had at least one CMB and all had WMLs before LAAO, which may be explained by the large proportion of patients with previous intracerebral hemorrhage (52.4%) and hypertension (90.5%). Our findings on susceptibilityweighted imaging in patients with pre-and post-interventional MRI do not suggest that the procedure increases the short-term risk of cerebral bleeding.
Our study has strengths in that it was a prospective trial with consecutive recruitment and standardized clinical and radiological work-up, including state-ofthe-art MRI. Limitations include the low number of included patients, which affects the precision and statistical power of our analysis, performance at a single center and the absence of a control group. Finally, our pilot study did not allow assessment of the influence of a particular device.
In conclusion, we found a comparatively low rate of new post-interventional DWI lesions after LAAO. Further evaluation in larger multicenter studies is necessary. 
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